Detection of chimerism by PCR analysis of short tandem repeats (STR) in blood samples of patients who received allogeneic bone marrow transplantation (BMT) has proved to be an important method for early detection of relapse. The prerequisite for this type of analysis is knowledge of donor and recipient pretransplantation genotypes. In some cases, recipient cells from time points prior to BMT are not available and the pretransplant fingerprint cannot be determined. As BM recipients only alter their genotype in blood cells, we attempted to identify patient's pretransplantation genotypes after transplantation in mouthwash samples that contain easily accessible epithelial cells. Of 17 patients who had undergone BMT between one week and 45 months prior to analysis, DNA was isolated from mouthwash cell pellets or from epithelial cells obtained from mouthwashes. PCR analysis of STR loci in the von Willebrand and the tyrosine hydroxylase genes were performed. Even though the mouthwash cell pellets contained about 75% epithelial cells (presumably of recipient origin) and only about 25% leukocytes (presumably of donor origin), three of five patients showed donor genotype and only two patients exhibited chimeric DNA patterns, when cellular DNA was obtained by boiling of mouthwash cell pellets. Following phenol/chloroform extraction, eight of 10 DNA samples exhibited a chimeric pattern, while two of 10 DNAs showed only donor genotype. Of three patients, epithelial cells were attached to magnetic beads prior to DNA isolation. Even this DNA contained donor and recipient material. From our results it appears that blood cells serve as preferential DNA source in mouthwash samples and cannot be removed by epithelial cell separation. Keywords: genetic fingerprinting; mouthwash; allogeneic bone marrow transplantation 
of recipient origin. It has been shown, that the success of BMT is directly related to engraftment of donor cells. [1] [2] [3] Therefore, testing for donor cells in the blood of transplanted patients has gained increasing importance. Analysis of hematopoietic chimerism in the patients' blood can provide a measure of engraftment of bone marrow as well as of residual disease and detection of incipient relapse.
3,4 PCR (polymerase chain reaction) amplification of highly variable DNA regions (short tandem repeats, STR, variable number of tandem repeats, VNTR) has greatly improved sensitivity and specificity of these tests. To be able to perform this type of analysis, the donor and the recipient genotype have to be known and must be distinguishable. Sometimes, patient material from time points prior to transplantation is not available and the pretransplantation genotype cannot be determined. In our study, we tested DNA sources that could be useful to identify pretransplantation genotypes. As mouthwashes contain large amounts of easily accessible epithelial cells and have proved to be a useful DNA source for PCR analysis, 5 we evaluated the possibility of defining the recipient DNA pattern in mouthwash samples. We studied patients who had undergone BMT 1 week to 45 months prior to the investigation.
Materials and methods

Patients
Seventeen patients who had undergone BMT for various hematological diseases (Table 1) , and from whom pretransplant blood samples were available for comparison, were tested. All patients had received non T cell-depleted bone marrow between November 1993 and October 1997. The mean time elapsed after transplantation was 12.9 months (range 1 week to 48 months). All patients showed complete hematological remission (CHR) and donor genotype in their blood at the time of PCR analysis. The pretransplantation genotypes of all 17 transplant recipients were known and could be distinguished from their donors in either one of the following two STR systems: von Willebrand factor intron 40 (vWF) or tyrosine hydroxylase gene (TH01).
DNA preparations
Prior to transplantation blood samples of all recipients and donors were collected and stored at Ϫ20°C. Cellular DNA was obtained by freezing and thawing the blood and boiling it for 10 min. After centrifugation for 3 min at 16 000 g the supernatants were collected, diluted 1:10 with water and used for PCR analysis. All pretransplant blood samples were preserved for comparison with mouthwash samples obtained after transplantation.
Mouthwashes
All patients were asked to rinse their mouth with 5 ml water for 30 s. Mouthwashes were collected and centrifuged immediately at 1000 g for 10 min. The supernatants were discarded, the pellets resuspended in 0.5 ml water and stored frozen at Ϫ80°C until further processing. After thawing aliquots (300 l) of mouthwash, cell pellet suspensions of patients 1, 2, 3, 4 and 16 were boiled for 10 min and centrifuged for 3 min at 16 000 g. The supernatants were used for PCR amplification as described by Lench et al. 6 For patients 5 to 14, DNA was isolated from the 0.5 ml cell pellet suspensions by phenol/chloroform extraction according to Sambrook et al. 7 All DNA samples were analyzed by electrophoresis on 1% agarose gels followed by ethidium bromide staining. Only a small portion of the DNA was fragmented, while most of the DNA was present in a high molecular weight form (at least 20 kb long).
For patients 15, 16 and 17, epithelial cells were separated from freshly collected mouthwashes by the Dynabead antiepithelial cell kit (Dynal, Oslo, Norway).
Separation of epithelial cells
Fresh mouthwash samples were centrifuged at 2000 g for 10 min. The supernatants were decanted leaving behind approximately 500 l to resuspend the cell pellets. Aliquots of the suspensions (150 l) were incubated with 30 l Dynabead anti-epithelial cell antibody coated magnetic beads at 4°C for 30 min. Dynabead anti-epithelial cell antibody coated magnetic beads are paramagnetic monodisperse polymer particles coated with a monoclonal antibody directed against Ber-EP4, an antigen expressed exclusively on the surface of epithelial cells. 8 The beads were collected with the magnetic device supplied by the manufacturer and washed five times with phosphate-buffered saline (PBS) pH 7.4 containing 0.1% of bovine serum albumin (BSA). Cells attached to the beads were incubated with 10 l proteinase K (50 mg/ml) in a total volume of 100 l at 65°C for 2 h. After boiling for 10 min to inactivate proteinase K, 12 l aliquots were directly submitted to PCR analysis.
PCR amplification of STR loci in the vWF and TH-01 gene
PCR analyses of the VNTR region in intron 40 of the von Willebrand factor gene (vWF) (12p12) and of the TH01 locus (11p15.5) were performed essentially as described. 9 PCR products were assayed on precast 6% polyacrylamide gels (Novex, San Diego, CA, USA) at 150 V for 45 min. Gels were stained with Sybr Green I (Molecular Probes, Eugene, OR, USA) for 15 min.
Microscopic analysis of mouthwash samples
In 14 mouthwash samples a microscopic analysis was performed. A cytospin was prepared and stained with standard May-Grünwald and Giemsa. In all samples 72.5 Ϯ 16.3% of the cells were of epithelial origin, the rest were leukocytes. Trypan blue staining 10 indicated 58.0 Ϯ 10.7% of the epithelial cells to be viable.
Results and discussion
When mouthwash cells obtained after transplantation were boiled and the supernatants were subjected to PCR analysis, specimens from patients 1, 3 and 4 exhibited a donor genotype even though the cell pellets contained approximately 75% epithelial cells and only approximately 25% leukocytes. In samples from patients 2 and 16, a chimeric DNA pattern was detected. While patient 2 had been transplanted only 4 months prior to the investigation, patient 16 had received the graft 40 months previously. Interestingly, in both patients the underlying disease was CML. When phenol extracted nuclear DNA of patients 5 to 12 was tested, six of eight samples showed a chimeric genotype. These six patients had received the graft 7, 9, 11, 15 and 20 months prior to analysis. Two patients (5 and 11) could be tested with TH01 as well as vWF STR analysis, and corresponding results were obtained. The chimeric genotype was detectable by both methods. DNA samples of patients 6 (tested for Th01) and 8 (tested for vWF) exhibited only donor genotype. Transplantation in patient 6 was performed 17 months and, in patient 8, 36 months before the investigation. The results were surprising as one would not expect to see only the donor genotype in DNA extracted from a mixture of approximately 75% epithelial cells and approximately 25% leukocytes, especially as by Trypan blue staining a large percentage of the epithelial cells (Ͼ58%) was found to be viable, and most of the DNA that was isolated from mouthwash cell pellets was of high molecular weight. If we assume that epithelial cells remained of recipient origin, we must conclude from our data that blood cells are a more easily accessible DNA source than epithelial cells. The presence of a chimeric DNA population in the mouthwash of an individual was independent of the time elapsed between BMT and sampling of the mouthwashes. Mouthwash samples from patients 13 and 14 could be analyzed at 1 week intervals starting on day 0 of BMT up to week 4. As soon as 2 weeks after BMT a chimeric genotype could be detected in mouthwashes from both patients ( Figure 1 shows the data of patient 13), which originated from the presence of leukocytes (of donor origin) and epithelial cells (of recipient origin).
Epithelial cells were separated from mouthwash samples of patients 15, 16 and 17 on dynabeads. All three epithelial cell lysates contained DNA of donor as well as recipient origin. The recipient genotype dominated ( Figure 2 lane 4 depicts the results of patient 16), and could be easily discerned from the donor genotype in all three samples. These results show that under certain conditions it is possible to determine a patient's pretransplant genotype in mouthwash samples collected after transplantation.
However, we were surprised that even after separation of epithelial cells, DNA extracted from these cells was composed of recipient and donor material. We assume that not only epithelial cells but also blood cells attached to the magnetic beads. 11 This should be kept in mind for all applications of magnetic beads for epithelial cell separation.
